Cyclosporine and its metabolites in mother and baby by Venkataramanan, R et al.
468 TRANSPLANTATION Vol. 46, No.3 
become useful as a provocative and predictive test for early 
renal abnormalities. 
In summary, our data indicate that exercise microalbumi-
nuria is not detected in most kidney donors and support the 
notion that the uninephrectomized state does not result in a 
progressive hyperfiltration nephropathy. In addition, longitu-
dinal studies could reveal whether. a particular subset of donors 
with abnormal exercise albuminuria represent an early phase 
of overt proteinuria and kidney damage. 
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CYCLOSPORINE AND ITS METABOLITES IN MOTHER AND BABY 
Cyclosporine (CsA) is a potent immunosuppressive agent 
that has significantly improved allograft survival in recipients 
of human organ transplants (1, 2). Recently there have been a 
few cases of successful pregnancies in transplant patients re-
ceiving CsA alone or in combination with steroids (3, 4). A 
general concern regarding pregnancy in transplant patients is 
the potential harmful effect of chronic maternal immuno-
- suppression on the fetus. It is essential to determine the extent 
of exposure of the fetus to the immunosuppressive drug and its 
metabolites. We recently studied the concentrations of CsA 
and several of its metabolites in maternal and cord blood, 
placenta, and the umbilical cord in two patients receiving 
chronic CsA therapy. 
The first patient was a 26-year-old woman with primary 
biliary cirrhosis secondary to common bile duct obstruction 
who received a successful liver transplantation in November 
1985. Immunosuppression was achieved with CsA and steroids. 
During the second postoperative week she also received the 
monoclonal antibody OKT 3. In February 1987, she delivered 
a 3208 g baby boy. At the time of delivery she was receiving 
esA 200 mg orally h.i.d., prednisone 10 mg, hydralazine 50 mg 
q.i.d., ferrous sulphate 300 t.i.d, furosemide 40 mg q.d. and 
multivitamin therapy. On the day of the delivery she received 
CsA at 10 A.M. and the baby was born at 5:45 P.M. Maternal 
blood was obtained at 8.5 hr after CsA administration while 
cord blood was obtained at 7.8 hr after CsA administration. 
Moternul and cord blood along with placenta and umbilical 
cord were annlyzed for CsA and several of its metabolites using 
a gradient high-pressure liquid chromatographic method devel-
oped in our laboratory (5). 
The second patient was a 25-year-old woman who received 
an orthotopic liver transplant in November 1985 for cirrhosis 
of unknown cause. Immunosuppression was achieved with CsA 
and steroids. Four weeks following the transplant, the patient 
developed cytomegalovirus hepatitis from which she recovered 
with reduction in immunosuppression. She did well for 10 
months and then developed biliary obstruction that was cor-
rected surgically. At this time she became pregnant. Pregnancy 
was complicated by anemia requiring blood transfusions and 
preeclampsia. At gestational age 36 weeks, she had a caesarean 
section because of fetal distress, and a live baby boy (weight 
1690 g) was delivered at 8 A.M. At the time of delivery her 
medications included Riopan 30 ml p.o. every 4 hr, ranitidine 
150 mg orally b.i.d., ferrous sulfate 300 mg orally t.i.d., pred-
nisone 15 mg orally every day and CsA 125 mg orally every 12 
hr. Maternal and fetal cord blood were drawn simultaneously 
at the time of delivery 10 hr after the previous oral cyclosporine 
dose. The baby had intrauterine growth retardation, as the 
weight and head circumference were below the fifth percentile. 
The blood samples, umbilical cord, and placenta were refriger-
ated at 4°C until analyzed by HPLC. 
Table 1 lists the concentrations of CsA and its metabolites 
in blood and in different tissues. The highest concentration of 
CsA was seen in the umbilical cord of patient 1. The placenta 
contained CsA concentrations nearly five to ten times greater 
thon the maternul llnd the fetal blood, und had the highest 
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TABLE 1. Cyclosporine and its metabolites in mother and child" 
CyA 
M-17 
M-21 
M-l 
M-18 
Maternal 
blood 
(ng/ml) 
90, 105 
134, 132 
<25,0 
89, 63 
0, <25 
Cord hlood 
(ng/ml) 
53,55 
159, 162 
0,0 
28, 0 
0,0 
Placenta 
(ng/g) 
506, 318 
481, 184 
<25,0 
229, 89 
0,0 
Umbilical 
cord 
(ng/g) 
2641, <25 
137,97 
0,0 
28,0 
0,0 
• The first value was observed in patient 1 and the second value was 
observed in patient 2. 
concentrations of all the metabolites measured. While small 
concentrations of M 21 were observed in the placenta and the 
maternal blood of patient 1, M 18 concentrations were below 
measurable levels in most of the specimens. 
Cyclosporine is very lipid-soluble, extensively distributed in 
the body, and highly metabolized. Previous studies have re-
ported the presence of CsA in cord blood, placenta, amniotic 
fluid, and breast milk (4). In addition to CsA, we have observed 
high concentrations of CsA metabolites in the placenta, indi-
cating the presence of CsA metabolizing enzymes in this tissue 
and/or accumulation of these metabolites in the placenta. Very 
high concentrations of CsA (nearly 30 times that of the mater-
nal blood) were also observed in the umbilical cord of one 
patient. Some of the metabolites, particularly M 17, appear in 
very high concentrations in the blood and also possess signifi-
cant immunosuppressive effect (6, 7). Whether the metabolites 
of CsA also contribute to the toxicity is not known. In this 
study we report for the first time the concentrations of CsA 
metabolites in cord blood, placenta, and umbilical cord. Of 
interest is the relatively high concentration of all the metabo-
lites in the placenta. 
While no specific harmful effects attributable to CsA were 
observed in the baby, it is clear that the fetus is exposed not 
only to CsA but also to its metabolites. According to the tests 
conducted by Sandoz Inc. (Basel, Switzerland) CsA is not 
mutagenic in the Ames test and did not produce any chromo-
somal abnormalities in animals. However, since the fetus is 
exposed to chronic CsA and its metabolites. the immediate 
septic complications and the possible long-term effects on 
gestationally immunosuppressed children should be investi-
gated. 
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Reconstruction of the hepatic artery is an essential step in 
human hepatic transplantation. Thrombosis of the hepatic 
arterial anastomosis posttransplantation is the most frequent 
arterial complication (1, 2), particularly in small children (3). 
Mycotic aneurysms involving the hepatic arterial anastomosis 
are reported to occur much less frequently. In a series of 86 
orthotopic hepatic transplantations performed (46 in children 
at the Cochin Hospital we have observed three cases of hepatic 
artery thrombosis. We have had two cases of anastomotic 
mycotic hepatic artery aneurysms occurring in the early post-
operative period. The aim of this article is to discuss the 
diagnostic circumstances and therapeutic options of this serious 
complication, and to analyse the consequences of the resection 
of the aneurysm with deliberate ligation of the hepatic artery, 
which was the treatment used in our two patients. 
Case 1. An 18-year-old female patient suffering from cirrhosis 
due to chronic active viral hepatitis (type B) was transferred 
to the Cochiri Hospital on 8/18/86 for hepatic transplantation. 
She had previously undergone an elective distal splenorenal 
shunt for bleeding esophageal varices, following which hepatic 
function had continued to deteriorate. Clinically, she was 
deeply jaundiced with significant wasting. Prothrombin index 
was 22%. On 9/11/86, an orthotopic hepatic transplantation 
without extracorporeal venovenous bypass was performed using 
the liver of a 19-year-old man. No antibiotic was administered 
to the donor. Cold ischemia time was 5 hr 20 min and the 
anhepatic phase was 1 hr 20 min. The hepatic arterial anasto-
mosis between the recipient hepatic artery proper and the donor 
common hepatic artery was performed with continuous 7/0 
prolene. Biliary continuity was reestablished with a Roux-en-
Y hepaticojejunostomy. The splenorenal anastomosis was 
. permeable and was not suppressed. Intraoperative transfusion 
was 25 units of packed cells. Routine immunosuppression with 
corticosteroids and cyclosporine was commenced. Mezlocillin, 
gentamycin and ornidazole were administered during the first 
48 hr. On the 12th postoperative day the patient became febrile 
and suffered an intraabdominal hemorrhage. A CT scan showed 
a subhepatic hematoma, and angiography showed a small he-
